Tyler Collins is a tax partner with over 12 years of experience in the profession. As the Market Leader of Withum’s R&D tax credit services, he helps clients maximize their tax savings by identifying and capturing eligible research and development expenses.
Driven by a passion for innovation and a commitment to excellence, Tyler provides expert guidance on navigating complex tax regulations, ensuring clients fully leverage available credits to fuel innovation and growth within their organizations. By optimizing R&D tax credits, businesses can invest more in research and development initiatives, driving technological advancement and competitive advantage in their industries.
Tyler is an integral member of Withum’s tax team. He assists in creating and executing the team’s strategic vision and short- and long-term plans.
Learn more about my professional experience and how I spend my time outside the firm.
Education:
Professional Affiliations:
As an industry expert, Tyler shares his knowledge through multiple avenues. He is a published author of several articles on the R&D tax credit and has been quoted by Thomson Reuters Tax and Accounting. Tyler has spoken at several CPE venues including the CPA Academy and AICPA ENGAGE.
Outside of the office, Tyler enjoys exploring new places and experiencing different cultures while traveling, particularly local cuisines, which he uses for inspiration in his own kitchen. When he is not jet-setting, he enjoys DIY house projects and transforming spaces with a touch of creativity.
The R&D tax credit under IRC §41 is a statutory tax incentive, not a discretionary benefit, designed to reward companies for investing in innovation in the United States. While the opportunity can be significant, the credit is highly technical and documentation driven. At Withum, we believe the quality of an R&D tax credit study should…
A recent shift in federal policy materially changes how certain cannabis businesses should evaluate their Research and Development (R&D) Tax Credit position. On April 22, 2026, the Drug Enforcement Administration (DEA) issued a final order rescheduling specific cannabis products from Schedule I to Schedule III under the Controlled Substances Act. This change applies primarily to…
The Research and Development (“R&D”) tax credit under Internal Revenue Code (“IRC”) §41 is a statutory tax incentive, not a discretionary benefit. During an audit, the Internal Revenue Service (“IRS”) does not evaluate whether a taxpayer’s work “looks innovative”. Instead, examiners apply a structured, statute driven analysis grounded in §41, the Treasury Regulations, and the…